BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 21615408)

  • 41. Two deubiquitylases act on mitofusin and regulate mitochondrial fusion along independent pathways.
    Anton F; Dittmar G; Langer T; Escobar-Henriques M
    Mol Cell; 2013 Feb; 49(3):487-98. PubMed ID: 23317502
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
    Hattori N
    Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy.
    Burchell VS; Nelson DE; Sanchez-Martinez A; Delgado-Camprubi M; Ivatt RM; Pogson JH; Randle SJ; Wray S; Lewis PA; Houlden H; Abramov AY; Hardy J; Wood NW; Whitworth AJ; Laman H; Plun-Favreau H
    Nat Neurosci; 2013 Sep; 16(9):1257-65. PubMed ID: 23933751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Disease-causing mutations in parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy.
    Lee JY; Nagano Y; Taylor JP; Lim KL; Yao TP
    J Cell Biol; 2010 May; 189(4):671-9. PubMed ID: 20457763
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control.
    McLelland GL; Soubannier V; Chen CX; McBride HM; Fon EA
    EMBO J; 2014 Feb; 33(4):282-95. PubMed ID: 24446486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Juvenile Huntington's Disease Skin Fibroblasts Respond with Elevated Parkin Level and Increased Proteasome Activity as a Potential Mechanism to Counterbalance the Pathological Consequences of Mutant Huntingtin Protein.
    Aladdin A; Király R; Boto P; Regdon Z; Tar K
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31717806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Parkin promotes proteasomal degradation of p62: implication of selective vulnerability of neuronal cells in the pathogenesis of Parkinson's disease.
    Song P; Li S; Wu H; Gao R; Rao G; Wang D; Chen Z; Ma B; Wang H; Sui N; Deng H; Zhang Z; Tang T; Tan Z; Han Z; Lu T; Zhu Y; Chen Q
    Protein Cell; 2016 Feb; 7(2):114-29. PubMed ID: 26746706
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ubiquitin-proteasome-dependent degradation of a mitofusin, a critical regulator of mitochondrial fusion.
    Cohen MM; Leboucher GP; Livnat-Levanon N; Glickman MH; Weissman AM
    Mol Biol Cell; 2008 Jun; 19(6):2457-64. PubMed ID: 18353967
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The deubiquitinase USP15 antagonizes Parkin-mediated mitochondrial ubiquitination and mitophagy.
    Cornelissen T; Haddad D; Wauters F; Van Humbeeck C; Mandemakers W; Koentjoro B; Sue C; Gevaert K; De Strooper B; Verstreken P; Vandenberghe W
    Hum Mol Genet; 2014 Oct; 23(19):5227-42. PubMed ID: 24852371
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Parkin ubiquitinates and promotes the degradation of RanBP2.
    Um JW; Min DS; Rhim H; Kim J; Paik SR; Chung KC
    J Biol Chem; 2006 Feb; 281(6):3595-603. PubMed ID: 16332688
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ubiquitin-protein ligase parkin and its role in the development of Parkinson's disease.
    Buneeva OA; Medvedev AE
    Biochemistry (Mosc); 2006 Aug; 71(8):851-60. PubMed ID: 16978147
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The role of parkin in Parkinson's disease].
    Miklya I; Göltl P; Hafenscher F; Pencz N
    Neuropsychopharmacol Hung; 2014 Jun; 16(2):67-76. PubMed ID: 24978049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Proteasome inhibition promotes Parkin-Ubc13 interaction and lysine 63-linked ubiquitination.
    Lim GG; Chew KC; Ng XH; Henry-Basil A; Sim RW; Tan JM; Chai C; Lim KL
    PLoS One; 2013; 8(9):e73235. PubMed ID: 24023840
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Linking F-box protein 7 and parkin to neuronal degeneration in Parkinson's disease (PD).
    Zhou ZD; Sathiyamoorthy S; Angeles DC; Tan EK
    Mol Brain; 2016 Apr; 9():41. PubMed ID: 27090516
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Bit-by-bit autophagic removal of parkin-labelled mitochondria.
    Yang JY; Yang WY
    Nat Commun; 2013; 4():2428. PubMed ID: 24013556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Parkin promotes proteasomal degradation of synaptotagmin IV by accelerating polyubiquitination.
    Kabayama H; Tokushige N; Takeuchi M; Kabayama M; Fukuda M; Mikoshiba K
    Mol Cell Neurosci; 2017 Apr; 80():89-99. PubMed ID: 28254618
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hepatitis B virus disrupts mitochondrial dynamics: induces fission and mitophagy to attenuate apoptosis.
    Kim SJ; Khan M; Quan J; Till A; Subramani S; Siddiqui A
    PLoS Pathog; 2013; 9(12):e1003722. PubMed ID: 24339771
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Parkin promotes degradation of the mitochondrial pro-apoptotic ARTS protein.
    Kemeny S; Dery D; Loboda Y; Rovner M; Lev T; Zuri D; Finberg JP; Larisch S
    PLoS One; 2012; 7(7):e38837. PubMed ID: 22792159
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitofusin 1 and 2 play distinct roles in mitochondrial fusion reactions via GTPase activity.
    Ishihara N; Eura Y; Mihara K
    J Cell Sci; 2004 Dec; 117(Pt 26):6535-46. PubMed ID: 15572413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.